Condensed Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Common Stock [Member]	Additional Paid In Capital [Member]	Accumulated Other Comprehensive Loss [Member]	Accumulated Deficit [Member]
Beginning Balance at Dec. 31, 2021	$ 278,220	$ 5	$ 372,284	$ 0	$ (94,069)
Beginning Balance (in shares) at Dec. 31, 2021		39,175,279
Shares released from restriction upon vesting of early-exercised stock options	27		27
Shares released from restriction upon vesting of early-exercised stock options (in shares)		53,483
Exercise of common stock options	276		276
Exercised		295,764
Stock-based compensation	4,550		4,550
Net loss	(23,533)				(23,533)
Ending Balance at Mar. 31, 2022	259,540	$ 5	377,137	0	(117,602)
Ending Balance (in shares) at Mar. 31, 2022		39,524,526
Beginning Balance at Dec. 31, 2021	278,220	$ 5	372,284	0	(94,069)
Beginning Balance (in shares) at Dec. 31, 2021		39,175,279
Net loss	(46,169)
Ending Balance at Jun. 30, 2022	242,429	$ 5	382,937	(275)	(140,238)
Ending Balance (in shares) at Jun. 30, 2022		39,630,397
Beginning Balance at Mar. 31, 2022	259,540	$ 5	377,137	0	(117,602)
Beginning Balance (in shares) at Mar. 31, 2022		39,524,526
Shares released from restriction upon vesting of early-exercised stock options	25		25
Shares released from restriction upon vesting of early-exercised stock options (in shares)		52,208
Exercise of common stock options	12		12
Exercised		1,962
Vesting of shares of restricted common stock (in shares)		14,916
Issuance of common stock for Employee Stock Purchase Plan	211		211
Issuance of common stock for Employee Stock Purchase Plan (in Shares)		36,785
Other comprehensive loss	(275)			(275)
Stock-based compensation	5,552		5,552
Net loss	(22,636)				(22,636)
Ending Balance at Jun. 30, 2022	242,429	$ 5	382,937	(275)	(140,238)
Ending Balance (in shares) at Jun. 30, 2022		39,630,397
Beginning Balance at Dec. 31, 2022	218,162	$ 6	404,386	403	(185,827)
Beginning Balance (in shares) at Dec. 31, 2022		41,095,564
Shares released from restriction upon vesting of early-exercised stock options	25		25
Shares released from restriction upon vesting of early-exercised stock options (in shares)		30,392
Exercise of common stock options	117		117
Exercised		109,913
Vesting of shares of restricted common stock (in shares)		110,021
Other comprehensive loss	340			340
Stock-based compensation	6,000		6,000
Net loss	(24,561)				(24,561)
Ending Balance at Mar. 31, 2023	200,083	$ 6	410,528	(63)	(210,388)
Ending Balance (in shares) at Mar. 31, 2023		41,345,890
Beginning Balance at Dec. 31, 2022	$ 218,162	$ 6	404,386	403	(185,827)
Beginning Balance (in shares) at Dec. 31, 2022		41,095,564
Exercised	146,718
Net loss	$ (51,058)
Ending Balance at Jun. 30, 2023	247,722	$ 7	484,666	(66)	(236,885)
Ending Balance (in shares) at Jun. 30, 2023		49,916,220
Beginning Balance at Mar. 31, 2023	200,083	$ 6	410,528	(63)	(210,388)
Beginning Balance (in shares) at Mar. 31, 2023		41,345,890
Issuance of common stock, Value	67,481	$ 1	67,480
Shares released from restriction upon vesting of early-exercised stock options	26		26
Issuance of common stock, (in shares)		8,369,754
Shares released from restriction upon vesting of early-exercised stock options (in shares)		30,390
Exercise of common stock options	65		65
Exercised		35,805
Vesting of shares of restricted common stock (in shares)		42,941
Issuance of common stock for Employee Stock Purchase Plan	256		256
Issuance of common stock for Employee Stock Purchase Plan (in Shares)		91,440
Other comprehensive loss	(3)			(3)
Stock-based compensation	6,311		6,311
Net loss	(26,497)				(26,497)
Ending Balance at Jun. 30, 2023	$ 247,722	$ 7	$ 484,666	$ (66)	$ (236,885)
Ending Balance (in shares) at Jun. 30, 2023		49,916,220